Jump to content

Pages with the most revisions

Showing below up to 50 results in range #751 to #800.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Effect:Appetite intensification (2 revisions)
  2. Effect:Stimulation (2 revisions)
  3. Phenotype:TPMT normal metabolizer (2 revisions)
  4. Olopatadine (2 revisions)
  5. Effect:Magnification (2 revisions)
  6. Phenotype:UGT1A1 poor metabolizer (2 revisions)
  7. Cyanocobalamin (2 revisions)
  8. Effect:Hallucinations (2 revisions)
  9. Problem:Impulsivity (2 revisions)
  10. Ipratropium (2 revisions)
  11. Effect:Bronchodilation (2 revisions)
  12. Problem:Trichotillomania (2 revisions)
  13. Effect:Stereotyped behaviors (2 revisions)
  14. Problem:Alcohol Use Disorder (2 revisions)
  15. Eptinezumab (2 revisions)
  16. Effect:Physical euphoria (2 revisions)
  17. Problem:Agitation (2 revisions)
  18. Hydrocortisone (2 revisions)
  19. Effect:Unspeakable horrors (2 revisions)
  20. Problem:Inflammatory Bowel Disease (2 revisions)
  21. Celecoxib (2 revisions)
  22. Effect:Environmental cubism (2 revisions)
  23. Problem:BPH (2 revisions)
  24. Effect:Reduced obsessive thoughts (2 revisions)
  25. Problem:Dry eye disease (2 revisions)
  26. Glimepiride (2 revisions)
  27. Effect:Motivation enhancement (2 revisions)
  28. Problem:Other Specified Dissociative Disorder (2 revisions)
  29. Sitagliptin (2 revisions)
  30. Effect:Changes in felt gravity (2 revisions)
  31. Problem:Glaucoma (2 revisions)
  32. Fexofenadine (2 revisions)
  33. Effect:Component controllability (2 revisions)
  34. Problem:VTE prevention or treatment (2 revisions)
  35. Effect:Increased music appreciation (2 revisions)
  36. Problem:Chronic kidney disease in type 2 diabetes (2 revisions)
  37. Cholecalciferol (2 revisions)
  38. Effect:Pattern recognition enhancement (2 revisions)
  39. Effect:Insomnia (2 revisions)
  40. Turmeric (2 revisions)
  41. Simvastatin (2 revisions)
  42. Effect:Atemporality (2 revisions)
  43. Effect:Itchiness (2 revisions)
  44. Amoxicillin (2 revisions)
  45. Effect:Coincidence intensification (2 revisions)
  46. Effect:Pain relief (2 revisions)
  47. Phenotype:NUDT15 intermediate metabolizer (2 revisions)
  48. Effect:Double vision (2 revisions)
  49. Phenotype:CYP2C19 poor metabolizer (2 revisions)
  50. Meloxicam (2 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)